Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Citi
Healthtrust
Teva
UBS

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 9,365,572

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,365,572
Title:PI3K and/or mTOR inhibitor
Abstract: The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt, a stereoisomer or a solvate thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, X, Y, A and B are as defined in the specification. The present invention further relates to a method for preparing these compounds, a pharmaceutical composition containing these compounds, and a use of these compounds in manufacture of a medicament for treating and/or preventing proliferative diseases. ##STR00001##
Inventor(s): Wu; Frank (Jinan, CN), Shu; Chutian (Jinan, CN)
Assignee: Xuanzhu Pharma Co., Ltd. (Jinan, Shandong Province, CN)
Application Number:14/427,665
Patent Claims:see list of patent claims

Details for Patent 9,365,572

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up Xuanzhu Pharma Co., Ltd. (Jinan, Shandong Province, CN) 2032-09-12 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up Xuanzhu Pharma Co., Ltd. (Jinan, Shandong Province, CN) 2032-09-12 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Xuanzhu Pharma Co., Ltd. (Jinan, Shandong Province, CN) 2032-09-12 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Baxter
Fuji
McKesson
US Army
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.